Seguir
Vathany Kulasingam
Vathany Kulasingam
University Health Network
Dirección de correo verificada de uhn.ca
Título
Citado por
Citado por
Año
Strategies for discovering novel cancer biomarkers through utilization of emerging technologies
V Kulasingam, EP Diamandis
Nature clinical practice Oncology 5 (10), 588-599, 2008
8922008
Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients
VG Hall, VH Ferreira, T Ku, M Ierullo, B Majchrzak-Kita, C Chaparro, ...
New England Journal of Medicine 385 (13), 1244-1246, 2021
5472021
Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets
V Kulasingam, EP Diamandis
Molecular & cellular proteomics 6 (11), 1997-2011, 2007
2412007
Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer
V Kulasingam, MP Pavlou, EP Diamandis
Nature Reviews Cancer 10 (5), 371-378, 2010
1922010
Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines
C Planque, V Kulasingam, CR Smith, K Reckamp, L Goodglick, ...
Molecular & cellular proteomics 8 (12), 2746-2758, 2009
1702009
Mining the Ovarian Cancer Ascites Proteome for Potential Ovarian Cancer Biomarkers* S
C Kuk, V Kulasingam, CG Gunawardana, CR Smith, I Batruch, ...
Molecular & Cellular Proteomics 8 (4), 661-669, 2009
1622009
Quantitative measurement of anti-SARS-CoV-2 antibodies: analytical and clinical evaluation
V Higgins, A Fabros, V Kulasingam
Journal of clinical microbiology 59 (4), 10.1128/jcm. 03149-20, 2021
1342021
Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients
VG Hall, VH Ferreira, M Ierullo, T Ku, T Marinelli, B Majchrzak-Kita, ...
American Journal of Transplantation 21 (12), 3980-3989, 2021
1322021
Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma …
B Krastins, A Prakash, DA Sarracino, D Nedelkov, EE Niederkofler, ...
Clinical biochemistry 46 (6), 399-410, 2013
1252013
Circulating tumor DNA as a cancer biomarker: fact or fiction?
F Leung, V Kulasingam, EP Diamandis, DSB Hoon, K Kinzler, K Pantel, ...
Clinical chemistry 62 (8), 1054-1060, 2016
1072016
Tissue culture‐based breast cancer biomarker discovery platform
V Kulasingam, EP Diamandis
International journal of cancer 123 (9), 2007-2012, 2008
982008
“Product ion monitoring” assay for prostate-specific antigen in serum using a linear ion-trap
V Kulasingam, CR Smith, I Batruch, A Buckler, DA Jeffery, EP Diamandis
Journal of proteome research 7 (2), 640-647, 2008
962008
Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses
VG Hall, VH Ferreira, H Wood, M Ierullo, B Majchrzak-Kita, K Manguiat, ...
Nature Immunology 23 (3), 380-385, 2022
902022
Platform for establishing interlaboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assays
A Prakash, T Rezai, B Krastins, D Sarracino, M Athanas, P Russo, ...
Journal of proteome research 9 (12), 6678-6688, 2010
822010
Activated leukocyte cell adhesion molecule: a novel biomarker for breast cancer
V Kulasingam, Y Zheng, A Soosaipillai, AE Leon, M Gion, EP Diamandis
International journal of cancer 125 (1), 9-14, 2009
812009
Validation of a novel biomarker panel for the detection of ovarian cancer
F Leung, MQ Bernardini, MD Brown, Y Zheng, R Molina, RC Bast Jr, ...
Cancer Epidemiology, Biomarkers & Prevention 25 (9), 1333-1340, 2016
782016
Folate-receptor 1 (FOLR1) protein is elevated in the serum of ovarian cancer patients
F Leung, A Dimitromanolakis, H Kobayashi, EP Diamandis, V Kulasingam
Clinical biochemistry 46 (15), 1462-1468, 2013
772013
Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies
A Prakash, T Rezai, B Krastins, D Sarracino, M Athanas, P Russo, ...
Journal of proteome research 11 (8), 3986-3995, 2012
772012
Pediatric reference intervals for 28 chemistries and immunoassays on the Roche cobas® 6000 analyzer—A CALIPER pilot study
V Kulasingam, BP Jung, IM Blasutig, S Baradaran, MK Chan, M Aytekin, ...
Clinical biochemistry 43 (13-14), 1045-1050, 2010
672010
Urinary adenosine excretion in type 1 diabetes
H Rajasekeran, Y Lytvyn, A Bozovic, JA Lovshin, E Diamandis, D Cattran, ...
American Journal of Physiology-Renal Physiology 313 (2), F184-F191, 2017
632017
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20